CY1109903T1 - Αμινοπεπτιδαση β2324 - Google Patents

Αμινοπεπτιδαση β2324

Info

Publication number
CY1109903T1
CY1109903T1 CY20091101111T CY091101111T CY1109903T1 CY 1109903 T1 CY1109903 T1 CY 1109903T1 CY 20091101111 T CY20091101111 T CY 20091101111T CY 091101111 T CY091101111 T CY 091101111T CY 1109903 T1 CY1109903 T1 CY 1109903T1
Authority
CY
Cyprus
Prior art keywords
polypeptide
aminopeptidase
sequence
gene
native
Prior art date
Application number
CY20091101111T
Other languages
English (en)
Inventor
John C Joly
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of CY1109903T1 publication Critical patent/CY1109903T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Περιγράφεται βακτηριακό κύτταρο αρνητικό κατά Gram το οποίο είναι ανεπαρκές σε χρωμοσωμικό γονίδιο που είναι παρόν σε τέτοιο κύτταρο φυσικού τύπου το οποίο γονίδιο έχει τουλάχιστον 80% ταυτοσημία αλληλουχίας με την φυσική αλληλουχία του γονιδίου yfcK και κωδικοποιεί αμινοπεπτιδάση. Εναλλακτικά, βακτηριακό κύτταρο αρνητικό κατά Gram είναι ανεπαρκές σε χρωμοσωμικό γονίδιο που είναι παρόν σε τέτοιο κύτταρο φυσικού τύπου το οποίο γονίδιο κωδικοποιεί αμινοπεπτιδάση που έχει τουλάχιστον 80% ταυτοσημία αλληλουχίας με την φυσική αλληλουχία αμινοπεπτιδάσης b2324. Ο καθένας από αυτούς τους τύπους κυττάρων, όταν περιλαμβάνει νουκλεϊκό οξύ που κωδικοποιεί ετερόλογο πολυπεπτίδιο, παράγει αμινοτελικό μη διασπασμένο πολυπεπτίδιο όταν καλλιεργείται και το πολυπεπτίδιο ανακτάται, με σχεδόν μηδενική παραγωγή ρυπαίνοντας αμινοτελικού διασπασμένου πολυπεπτιδίου. Αντιστρόφως, παρέχεται μέθοδος διάσπασης αμινοτελικού αμινοξέος από πολυπεπτίδιο που περιλαμβάνει την επαφή του πολυπεπτιδίου με αμινοπεπτιδάση που έχει τουλάχιστον 80% ταυτοσημία αλληλουχίας με την φυσική αλληλουχία αμινοπεπτιδάσης b2324.
CY20091101111T 2001-09-13 2009-10-26 Αμινοπεπτιδαση β2324 CY1109903T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32235001P 2001-09-13 2001-09-13
EP02761635A EP1432793B1 (en) 2001-09-13 2002-09-12 Aminopeptidase b2324

Publications (1)

Publication Number Publication Date
CY1109903T1 true CY1109903T1 (el) 2014-09-10

Family

ID=23254494

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101111T CY1109903T1 (el) 2001-09-13 2009-10-26 Αμινοπεπτιδαση β2324

Country Status (22)

Country Link
US (3) US6921659B2 (el)
EP (1) EP1432793B1 (el)
JP (2) JP4831932B2 (el)
KR (2) KR100954641B1 (el)
CN (1) CN100552023C (el)
AT (1) ATE440134T1 (el)
AU (1) AU2002326884B2 (el)
BR (1) BR0212886A (el)
CA (1) CA2460309C (el)
CY (1) CY1109903T1 (el)
DE (1) DE60233417D1 (el)
DK (1) DK1432793T3 (el)
ES (1) ES2329880T3 (el)
HK (1) HK1062695A1 (el)
HU (3) HU225346B1 (el)
IL (2) IL160658A0 (el)
MX (1) MXPA04002326A (el)
NZ (2) NZ531516A (el)
PL (1) PL206286B1 (el)
PT (1) PT1432793E (el)
WO (1) WO2003023030A2 (el)
ZA (1) ZA200401752B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL206286B1 (pl) 2001-09-13 2010-07-30 Genentech Incgenentech Inc Komórka Gram-ujemnej bakterii, sposób wytwarzania heterologicznego peptydu, sposób zapobiegania odcinaniu N-końcowego aminokwasu, sposób odcinania N-końcowego aminokwasu i sposób wytwarzania skróconego polipeptydu
PL1733037T3 (pl) 2004-03-11 2015-04-30 Genentech Inc Sposób wytwarzania polipeptydów
US9637746B2 (en) 2008-12-15 2017-05-02 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways
CN105132387A (zh) * 2008-12-22 2015-12-09 绿光生物科学公司 用于制造化合物的组合物和方法
EP2566953B1 (en) 2010-05-07 2019-01-02 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through enzyme relocation
WO2012030980A1 (en) 2010-08-31 2012-03-08 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
EP2753702B1 (en) 2011-09-09 2021-12-15 GreenLight Biosciences, Inc. Cell-free preparation of carbapenems
DK3030671T3 (en) 2013-08-05 2019-01-21 Greenlight Biosciences Inc MODIFIED PROTEINS WITH A PROTEASE CLEANING PLACE
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
KR20230048162A (ko) 2015-03-30 2023-04-10 그린라이트 바이오사이언시스, 아이엔씨. 리보핵산의 무세포 생산
AU2017246458B2 (en) 2016-04-06 2022-08-11 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN106967658B (zh) * 2017-02-23 2020-09-15 郑州大学 一种提高Fab抗体表达量的方法
IL273887B (en) 2017-10-11 2022-09-01 Greenlight Biosciences Inc Methods and preparations for the production of nucleoside triphosphate and ribonucleic acid
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122004000009I1 (de) * 1984-08-16 2004-11-18 Savient Pharmaceuticals Inc Methode zur Herstellung von menschlichen Wachstumshormonen.
WO1986007380A1 (en) * 1985-06-04 1986-12-18 Takeda Chemical Industries, Ltd. Process for preparing polypeptide
US4865974A (en) * 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase
US4946783A (en) 1987-01-30 1990-08-07 President And Fellows Of Harvard College Periplasmic protease mutants of Escherichia coli
EP0300035B1 (en) 1987-01-30 1995-05-10 The President And Fellows Of Harvard College Periplasmic protease mutants of escherichia coli
JPH01181796A (ja) * 1988-01-14 1989-07-19 Ajinomoto Co Inc 組換えdna法を用いたポリペプチドの製造法
JP2844870B2 (ja) * 1989-07-21 1999-01-13 味の素株式会社 組み替えdna法によるポリペプチドの製造法
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5573923A (en) * 1993-12-22 1996-11-12 Eli Lilly And Company Method for removing N-terminal dipeptides from precursor polypeptides with immobilized dipeptidylaminopeptidase from dictyostelium discoideum
US6127144A (en) * 1993-12-23 2000-10-03 Cangene Corporation Method for expression of proteins in bacterial host cells
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
KR100369839B1 (ko) 1997-02-28 2003-06-12 주식회사 엘지생명과학 바실러스리케니포미스균주에서유래한아미노펩티다제,그의제조방법및이를이용한천연형단백질의제조방법
CA2352046A1 (en) * 1998-12-07 2000-06-15 Novozymes A/S Glucoamylases with n-terminal extensions
KR20020011399A (ko) * 1999-04-30 2002-02-08 파마시아 코포레이션 에어로모나스 아미노펩티다제로 ν-말단 알라닌 잔기를폴리펩티드로부터 제거하는 방법
KR100400638B1 (ko) 2000-12-06 2003-10-08 주식회사 엘지생명과학 재조합 인간 성장호르몬 유사체의 분리방법
PL206286B1 (pl) 2001-09-13 2010-07-30 Genentech Incgenentech Inc Komórka Gram-ujemnej bakterii, sposób wytwarzania heterologicznego peptydu, sposób zapobiegania odcinaniu N-końcowego aminokwasu, sposób odcinania N-końcowego aminokwasu i sposób wytwarzania skróconego polipeptydu

Also Published As

Publication number Publication date
NZ531516A (en) 2006-03-31
WO2003023030A3 (en) 2003-07-10
DE60233417D1 (en) 2009-10-01
CA2460309A1 (en) 2003-03-20
EP1432793A2 (en) 2004-06-30
US6921659B2 (en) 2005-07-26
EP1432793A4 (en) 2006-05-24
PL368463A1 (en) 2005-04-04
CN100552023C (zh) 2009-10-21
KR100956907B1 (ko) 2010-05-11
JP2011177189A (ja) 2011-09-15
US7632658B2 (en) 2009-12-15
HU225430B1 (en) 2006-11-28
KR20090018142A (ko) 2009-02-19
NZ544964A (en) 2007-08-31
JP4831932B2 (ja) 2011-12-07
MXPA04002326A (es) 2004-06-29
ATE440134T1 (de) 2009-09-15
PL206286B1 (pl) 2010-07-30
AU2002326884B2 (en) 2007-10-18
ZA200401752B (en) 2005-05-25
US7229787B2 (en) 2007-06-12
JP2005502359A (ja) 2005-01-27
HU0600309D0 (en) 2006-06-28
HUP0401869A2 (hu) 2004-12-28
HU225243B1 (en) 2006-08-28
HU0600310D0 (en) 2006-06-28
KR100954641B1 (ko) 2010-04-27
US20060019341A1 (en) 2006-01-26
EP1432793B1 (en) 2009-08-19
IL160658A (en) 2009-05-04
US20080160572A1 (en) 2008-07-03
CN1555412A (zh) 2004-12-15
HK1062695A1 (en) 2004-11-19
DK1432793T3 (da) 2009-12-07
US20030124664A1 (en) 2003-07-03
ES2329880T3 (es) 2009-12-02
HU225346B1 (en) 2006-10-28
IL160658A0 (en) 2004-08-31
JP5372061B2 (ja) 2013-12-18
BR0212886A (pt) 2004-10-13
WO2003023030A2 (en) 2003-03-20
KR20040041611A (ko) 2004-05-17
CA2460309C (en) 2012-07-10
PT1432793E (pt) 2009-11-24
HUP0401869A3 (en) 2005-06-28

Similar Documents

Publication Publication Date Title
CY1109903T1 (el) Αμινοπεπτιδαση β2324
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
BR9813608B1 (pt) célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ATE389666T1 (de) Hohe expressionsrate von proteinen
ATE421994T1 (de) Genexpressionsmethode
AU6020998A (en) Methods for production of proteins
AR016216A1 (es) Fragmento aislado de acidos nucleicos que codifica un polipeptido de por lo menos 40 aminoacidos, que tiene al menos un 80% de identidad, basado en elmetodo clustal de alineamiento, con una enzima de la biosintesis de carotenoides en semillas y plantas, gen quimerico, celula huesped transformada, po
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
AU2002314738A1 (en) Methods for the production of products in host cells
ATE402997T1 (de) Mutierte penicillin g acylasen
ATE315638T1 (de) Oxalacetat-hydrolase defiziente fungale wirtszellen
ES2196019T3 (es) Proteasa fungica.
DK0574347T3 (da) Hidtil ukendt svampeprotease
AU7843101A (en) Furin polypeptides with improved characteristics
EP1757684A3 (en) A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme
KR930013111A (ko) 바실러스의 파라-니트로벤질 에스테라제를 암호화하는 재조합 dna 화합물 및 발현벡터
HUP0500349A2 (hu) Eljárás polipeptidek előállítására
WO2023114831A3 (en) Improvement of dnase1l3 serum half-life
BR9907767A (pt) Fragmento de ácido nucléico isolado codificador de toda ou uma parte substancial de uma sintetase de ciclopropano, gene quimérico, célula hospedeira transformada, polipeptìdeo de sintetase de ciclopropano, método de alteração do nìvel de expressão de uma sintetase de ciclopropano em uma célula hospedeira, método de obtenção de um fragmento de ácido nucléico codificador de toda ou uma parte substancial de uma sequência de aminoácidos codificadora de uma sintetase de ciclopropano e produto
CY1116010T1 (el) Διαδικασια για παραγωγη πολυπεπτιδιων